Recombinant Single-chain Factor VIII (rVIII-SingleChain) in Chinese Participants With Hemophilia A Previously Treated With FVIII Products
Clinical trial NCT06738485 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06738485
- Sponsor
- CSL Behring
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-01-09
- Primary completion
- 2026-10-26
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.